• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Diseases
Mosquito icon

Dengue

Symptoms, transmission, and current treatments for dengue

Home > Diseases
Mosquito icon

Dengue

Symptoms, transmission, and current treatments for dengue

  • Overview
  • Facts

What is dengue?

Dengue is caused by a virus that is mostly transmitted by the bite of female mosquitoes of the species Aedes aegypti. Dengue symptoms range from none to serious flu-like symptoms. A small proportion of people develop severe dengue, which can be fatal.

There are four closely related dengue viruses, which are called dengue serotypes. Although recovery from infection gives immunity from the same dengue serotype, it also increases the risk of severe dengue if people are later infected by a different serotype.

Dengue is the most widely distributed mosquito-borne viral disease in the world. It continues to spread rapidly because of climate change, rapid urbanization, and population growth. Outbreaks are usually seasonal, peaking during and after rainy seasons. The World Health Organization classifies dengue as one of the top ten threats to public health.

What is the impact of dengue?

  • 3.9 billion people at risk
  • Endemic in 129 countries, with 80% of cases reported in the Americas
  • About 390 million infections per year, 96 million with symptoms
  • 85% increase in number of cases from 1990 to 2019
  • Puts immense pressure on health systems: it costs three times more to manage dengue than cholera
  • Most dengue cases are underreported with many cases asymptomatic, mild and self-managed, or misdiagnosed
Geographical distribution of dengue cases reported worldwide, 2021
Source: European Centre for Disease Prevention and Control

What are current treatments for dengue?

There are no specific antiviral drugs to treat dengue infection.  

Acetaminophen or paracetamol can be taken to control muscle aches, pains, and fever. Non-steroidal anti-inflammatory drugs such as ibuprofen and aspirin should be avoided.

Hospitalised dengue patients must be closely observed and their fluid intake carefully managed, according to strict guidelines. In countries where early detection and such medical care is available, the fatality rate from dengue has dropped to below 1%.

The currently available vaccine is limited to people aged 9-45 years old who have had at least one previous episode of dengue virus infection. Several additional dengue vaccine candidates are under evaluation.

The lack of treatment options increases the risk of people developing severe dengue, which is potentially fatal.  

What new treatments for dengue are needed?

Dengue-specific treatments are needed to treat the disease at different stages and to reduce the risk of an infection progressing to severe disease.

What dengue treatments are we working on?

We have establishing a global partnership with dengue-endemic countries to carry out pre-clinical studies and clinical trials to find a safe, affordable, and effective treatment for dengue. We are looking at repurposed drugs or drug combinations as well as pursuing a portfolio of dengue treatment options already in clinical development.

Find out about our work developing treatments for dengue.

How do you get dengue?

  • Insect bites: the virus that causes dengue can be transmitted by the bite of infected female mosquitoes of the species Aedes aegypti and, to a lesser extent, the species Aedes albopictus 
  • Mother-to-child: possible transmission from mother to child during pregnancy or childbirth
  • Rare cases of transmission via blood products, organ donation, and transfusions 

What are the symptoms of dengue?

Dengue
Dengue can have no symptoms or cause only mild illness, but it can also cause flu-like symptoms such as: 

  • high fever (40°C/104°F) 
  • severe headache
  • pain behind the eyes
  • nausea
  • vomiting
  • swollen glands
  • rash
  • muscle, joint, or bone pains so severe that dengue is sometimes referred to as ‘breakbone fever’

Severe dengue
Severe dengue happens when blood vessels become damaged and leaky, and the number of platelets (cells which form clots) drops. As a result, severe dengue can cause shock, internal bleeding, bleeding gums or nose, organ failure, and death. The symptoms of severe dengue include: 

  • severe abdominal pain 
  • persistent vomiting
  • rapid breathing
  • bleeding gums or nose
  • fatigue
  • restlessness
  • liver enlargement
  • blood in vomit or stool
  • potentially fatal 

How is dengue diagnosed?

Dengue infection can be diagnosed in several ways, all of which require a blood sample. Reverse transcriptase–polymerase chain reaction (RT–PCR) detects the virus directly and is the gold standard; it can be used in the first days after infection. Rapid diagnostic tests are also available, which test for a protein produced by the virus called NS1. Serological methods can be used to confirm recent (within the previous 3 months) or past infection. 

More information

  • WHO factsheet 

Last updated: January 2024

Living with dengue: ‘It’s everywhere and there’s nothing we can do about it.’

Tan Jhii Lian, infected by dengue twice in just three months in Malacca, Malaysia.
READ HER STORY

Making medical history for neglected patients

We develop urgently needed treatments for neglected patients and ensure they’re affordable, available, and adapted to the communities who need them

Young boy sitting on a hospital bed being examined by a nurse

Chagas disease

Causes heart and vital organ damage, after people are bitten by blood-sucking bugs

We delivered the first-ever treatment for children; now we’re searching for new drug candidates and working to boost access to care

Patient medical examination

Cryptococcal meningitis

Without treatment, deadly for thousands of people with advanced HIV

We’re working to improve access to life-saving treatments and developing an easier-to-use formulation

Girl with skin lesions on her nose

Cutaneous leishmaniasis

Leaves disfiguring, life-long scars that lead to severe social stigma

We’re working to develop safer, shorter treatments for this disabling disease

Doctor with young patient in hospital setting

Dengue

Rapidly spreading climate-sensitive disease with no specific treatment

We’re building a global partnership with dengue-endemic countries to develop a first treatment

Father walking in rural village with a cane and holding his son's hand

Filaria: river blindness

Lead to unbearable itching, disfiguring skin lesions, and even blindness

We’re working to develop a safe, effective, and affordable drug for the prevention and treatment of this debilitating disease

Young man standing in the street

Hepatitis C

Millions are left without treatment even though effective drugs exist

We’ve delivered a treatment as simple, safe, and effective as the best drugs available today – at a fraction of the cost 

Woman standing in front of her door house in a rural village in Sudan

Mycetoma

Often ends in amputation​, after people get infected from stepping on a thorn

We conducted the world’s first trial for an alternative to current treatments, which are toxic and difficult to administer

Mother holding her baby in her arms smiling

Paediatric HIV

Without treatment, half of children die before their second birthday

We’ve developed a strawberry-flavoured treatment to meet the needs of children long neglected by the global HIV response

Healthcare workers in a hospital

Pandemic Preparedness

The COVID-19 pandemic intensified global health inequalities

We’re bringing together partners and accelerating research to prepare for future viral pandemics in low-resource settings

Doctor diagnosing a man in a village with his hands on the man's neck

Sleeping sickness

Transmitted by the bite of a tsetse fly and causes severe neurological disorders

We delivered a revolutionary new drug to replace toxic treatments, and have ongoing trials to eliminate this disease

Girl looking over a fence

Visceral leishmaniasis

Is one of the world’s biggest parasitic killers, spread by the bites of sandflies

We’re working to develop a new generation of treatments to replace drugs that are painful, ineffective, and cause side effects

Chagas disease

Cryptococcal meningitis

Cutaneous leishmaniasis

Dengue

Filaria: river blindness

Hepatitis C

Mycetoma

Paediatric HIV

Pandemic Preparedness

Sleeping sickness

Visceral leishmaniasis

VIEW ALL DISEASES

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License